Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Programma finale completo - SIF - Università degli Studi di Torino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
204. Role of peroxisome proliferators activated receptors alpha (PPAR-) in acute<br />
pancreatitis induced by cerulean<br />
1 De Sarro Angelina, 1,2 Mazzon E., 1,2 Genovese T., 1,2 Di Paola R., 1 Muià C., 1 Malleo G.,<br />
3‡ Esposito E., Caputi A.P. 1,2 ., Cuzzocrea S. 1,2<br />
1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine,<br />
University of Messina, Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy;<br />
3 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università <strong>di</strong> Napoli “Federico II”, Napoli, Italy<br />
Chemioterapia antibatterica, antivirale e antineoplastica<br />
Poster 21 – 30<br />
205. Analysis of the thymidylate synthase gene structure in colorectal cancer patients,<br />
and its possible relation with the 5-fluorouracil drug response<br />
Sanguedolce Rosario 1 , Gulotta G. 2 , Cajozzo M. 3 , Agrusa A. 2 , Feo S. 4 , Sanguedolce G. 1 ,<br />
Calascibetta A. 1<br />
1 Dipartimento <strong>di</strong> Scienze Farmacologiche, 2 Chirurgia Generale e d’Urgenza, 3 Dipartimento <strong>di</strong><br />
Discipline Chirurgiche ed Oncologiche, 4 DOSAC. University of <strong>Stu<strong>di</strong></strong>es of Palermo<br />
138<br />
206. Irinotecan metronomic chemotherapy in metastatic colorectal cancer patients: a<br />
pharmacokinetic and pharmacodynamic study<br />
Bocci Guido 1 , Allegrini G. 2 , Fioravanti A. 1 , Orlan<strong>di</strong> P. 1 , Loupakis Fotios 2 , Barletta M. T. 2 , Di<br />
Paolo A. 1 , Falcone A. 2 , Danesi R. 1 , Del Tacca M. 1<br />
1 Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />
Pisa, Pisa; 2 Division of Me<strong>di</strong>cal Oncology, General Hospital, Livorno<br />
207. Adenosine receptor A3: role and expression in human thyroid cancer<br />
Pinto A., Morello S., Petrella A., Festa M., Popolo A., Parente L., Chiappetta G.*<br />
Department of Pharmaceutical Sciences, University of Salerno, Italy; *Tumor Institute,<br />
Fondazione Senatore G. Pascale, Naples, Italy<br />
208. Antimetastatic effect of a novel non competitive CXCR1/CXCR2 inhibitor in human<br />
melanoma<br />
*Bruno Annalisa, *Mosca M., *Buanne P., °Del Bufalo D., °Desideri M., °Giorgini S., § Ruco L.,<br />
*Allegretti M., *Gloaguen I., *Bizzarri C., * Melillo G., *Bertini R., °Zupi G.<br />
*Dompé pha.r.ma s.p.a., via Campo <strong>di</strong> Pile, 67100 L’AQUILA, ITALY; °Regina Elena Cancer<br />
Institute, via delle Messi d’Oro 156, 00158 ROME, ITALY; § S.Andrea Hospital, University La<br />
Sapienza, via <strong>di</strong> Grottarossa 1035, 00189 ROME, ITALY<br />
209. Pharmacokinetics of cisplatin during intraperitoneal hyperthermic chemotherapy<br />
perfusion (IHCP) in patients with peritoneal carcinomatosis<br />
*Cerretani Daniela, *Ferraro M. T., *Fiaschi A. I., *Miceli G. B.,**Cioppa T., **Marrelli<br />
D.,**Corso G.,**Pedrazzani C.,**Roviello F.<br />
*Department of Pharmacology “G. Segre”, University of Siena; **Department of Human<br />
Patology and Oncology, Unit of Surgical Oncolgy, University of Siena<br />
210. Effects of zoledronic acid on cathepsin K circulating levels in patients with bone<br />
metastasis<br />
Leto Gaetano¹, Tumminello F.M¹., Badalamenti G.², Incorvaia L.², Fulfaro F.², Crescimanno<br />
M.¹, Flan<strong>di</strong>na C.¹, Gebbia N.²<br />
¹Lab. Chemioter. Sperimentale and ²U.O. <strong>di</strong> Oncologia Me<strong>di</strong>ca, Dipartimento <strong>di</strong> Discipline<br />
Chirurgiche ed Oncologiche; Policlinico Universitario P. Giaccone, 90127 Palermo, Italy<br />
pag_sx.indd 1 30/05/2007 5.55.11